Background: In our earlier study, we have shown the memory enhancing and scopolamine-induced amnesia recovery properties of Ashwagandha leaf extract using behavioral paradigm and expression analysis of synaptic plasticity genes. Purpose: However, the exact mechanism through which Ashwagandha demonstrates these effects is still unknown. Methods: In the present study, we hypothesized that the alcoholic extract of Ashwagandha leaves (i-Extract) possesses cholinergic properties, which in turn inhibit the anti-cholinergic nature of scopolamine. Therefore, the potential of i-Extract to recover from the scopolamine-induced cholinergic deficits was assessed by measuring acetylcholine (neurotransmitter) and Arc (synaptic activity-related gene) expression level in the mouse brain. Results: The enzymatic activity of acetyl cholinesterase and choline acetyltransferase was assessed through colorimetric assays, and expression level of Arc protein was examined by Western blotting. Furthermore, mRNA level of these genes was examined by semi-quantitative reverse-transcriptase PCR. We observed that the treatment of i-Extract in scopolamine-induced amnesic mouse attenuates scopolamine-induced detrimental alterations in the cholinergic system. Conclusion: Thus, our study provided biochemical and molecular evidence of cholinergic properties of Ashwagandha leaf extract during brain disorders associated with cholinergic dysfunction.

Keywords:
Ashwagandha, Memory, Scopolamine, Arc, Acetyl cholinesterase, Choline acetyltransferase
1.
Mishra LC, Singh BB, Dagenais S: Scientific basis for the therapeutic use of Withania somnifera (Ashwagandha): a review. Altern Med Rev 2000;5:334-346.
2.
Verma SK, Kumar A: Therapeutic uses of Withania somnifera (Ashwagandha) with a note on withanolides and its pharmacological actions. Asian J Pharm Clin Res 2011;4:1-4.
3.
Jayanthi MK, Prathima C, Huralikuppi JC, et al: Anti-depressant effects of Withania somnifera fat (Ashwagandha ghrutha) extract in experimental mice. Int J Pharm Bio Sci 2012;3:33-42.
4.
Kulkarni SK, Dhir A: Withania somnifera: an Indian ginseng. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:1093-1105.
5.
Tohda C, Kuboyama T, Komatsu K: Dendrite extension by methanol extract of Ashwagandha (roots of Withania somnifera) in SK-N-SH cells. Neuroreport 2000;11:1981-1985.
6.
Jain S, Shukla SD, Sharma K, et al: Neuroprotective effects of Withania somnifera Dunn. in hippocampal sub-regions of female albino rat. Phytother Res 2001;15:544-548.
7.
Tohda C, Komatsu K, Kuboyama T: Scientific basis for the anti-dementia drugs of constituents from Ashwagandha (Withania somnifera) (Chemical & Pharmacological study). J Trad Med 2005;22:176-182.
8.
Widodo N, Kaur K, Shrestha BG, et al: Selective killing of cancer cells by leaf extract of Ashwagandha: identification of a tumor-inhibitory factor and the first molecular insights to its effect. Clin Cancer Res 2007;13:2298-2306.
9.
Shah N, Kataria H, Kaul SC, et al: Effect of the alcoholic extract of Ashwagandha leaves and its components on proliferation, migration, and differentiation of glioblastoma cells: combinational approach for enhanced differentiation. Cancer Sci 2009;100:1740-1747.
10.
Konar A, Shah N, Singh R, et al: Protective role of Ashwagandha leaf extract and its component withanone on scopolamine-induced changes in the brain and brain-derived cells. PLoS One 2011;6:e27265.
11.
Blokland A: Scopolamine-induced deficits in cognitive performance: a review of animal studies. Scopolamine Rev 2005:1-76.
12.
Ovsepian SV, Anwyl R, Rowan MJ: Endogenous acetylcholine lowers the threshold for long-term potentiation induction in the CA1 area through muscarinic receptor activation: in vivo study. Eur J Neurosci 2004;20:1267-1275.
13.
Soulé J, Alme M, Myrum C, et al: Balancing Arc synthesis, mRNA decay, and proteasomal degradation: maximal protein expression triggered by rapid eye movement sleep-like bursts of muscarinic cholinergic receptor stimulation. J Biol Chem 2012;287:22354-22366.
14.
Ellman GL, Courtney KD, Andres V Jr, et al: A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88-95.
15.
Chao LP, Wolfgram F: Spectrophotometric assay for choline acetyltransferase. Anal Biochem 1972;46:114-118.
16.
Bradford MM: Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
17.
Wang ZF, Tang XC: Huperzine A protects C6 rat glioma cells against oxygen-glucose deprivation-induced injury. FEBS Lett 2007;581:596-602.
18.
De Gois S, Houhou L, Oda Y, et al: Is RE1/NRSE a common cis-regulatory sequence for ChAT and VAChT genes? J Biol Chem 2000;275:36683-36690.
19.
Bock J, Thode C, Hannemann O, et al: Early socio-emotional experience induces expression of the immediate-early gene Arc/arg3.1 (activity-regulated cytoskeleton-associated protein/activity-regulated gene) in learning-relevant brain regions of the newborn chick. Neuroscience 2005;133:625-633.
20.
Xu Q, Walker D, Bernardo A, et al: Intron-3 retention/splicing controls neuronal expression of apolipoprotein E in the CNS. J Neurosci 2008;28:1452-1459.
21.
Archana R, Namasivayam A: Antistressor effect of Withania somnifera. J Ethnopharmacol 1999;64:91-93.
22.
Davis L, Kuttan G: Immunomodulatory activity of Withania somnifera. J Ethnopharmacol 2000;71:193-200.
23.
Klinkenberg I, Blokland A: The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies. Neurosci Biobehav Rev 2010;34:1307-1350.
24.
Bartus RT, Dean RL, Pontecorvo MJ, et al: The cholinergic hypothesis: a historical overview, current perspective, and future directions. Ann N Y Acad Sci 1985;444:332-358.
25.
García-Ayllón MS, Riba-Llena I, Serra-Basante C, et al: Altered levels of acetylcholinesterase in Alzheimer plasma. PLoS One 2010;5:e8701.
26.
Link W, Konietzko U, Kauselmann G, et al: Somatodendritic expression of an immediate early gene is regulated by synaptic activity. Proc Natl Acad Sci U S A 1995;92:5734-5738.
27.
Lyford GL, Yamagata K, Kaufmann WE, et al: Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites. Neuron 1995;14:433-445.
28.
Guzowski JF, Lyford GL, Stevenson GD, et al: Inhibition of activity-dependent arc protein expression in the rat hippocampus impairs the maintenance of long-term potentiation and the consolidation of long-term memory. J Neurosci 2000;20:3993-4001.
29.
Gil-Bea FJ, Solas M, Mateos L, et al: Cholinergic hypofunction impairs memory acquisition possibly through hippocampal Arc and BDNF downregulation. Hippocampus 2011;21:999-1009.
30.
Bloomer WA, VanDongen HM, VanDongen AM: Arc/Arg3.1 translation is controlled by convergent N-methyl-D-aspartate and Gs-coupled receptor signaling pathways. J Biol Chem 2008;283:582-592.
31.
Bramham CR, Wells DG: Dendritic mRNA: transport, translation and function. Nat Rev Neurosci 2007;8:776-789.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.